摘要
目的评价加替沙星与左氧氟沙星在治疗下呼吸道感染中的临床疗效和药物经济学效果。方法选择156例下呼吸道感染病例,随机分成2组,分别给予加替沙星与左氧氟沙星治疗,观察疗效并运用药物经济学方法进行分析。结果2组治疗方案的有效率分别为93.60%和91.00%,而左氧氟沙星组的成本效果比优于加替沙星组。结论药物经济学评价结果为左氧氟沙星组的成本效果比优于加替沙星组。
OBJECTIVE To evaluate the therapeutic efficacy and pharmacoeconomic results of two kinds of qulnolones in the treatment of lower respiratory tract infections. METHODS 156 patients with the treatment of lower respiratory tract infections were randomly divided into two groups, who were given gatifloxaein and levofloxiaein respectively. Therapeutic effects were observed and pharmaeoeconomie analysis was evaluated. RESULTS The total effective rates of gatifloxaein group and levofloxiaein group were 93.60% and 91.00%, pharmaeoeconomie analysis indicated the levofloxiaein was superior to gatifloxaein. CONCLUSION Pharmaeoeeonomie analysis indicated the levofloxiaein was superior to gatifloxaein in the treatment of lower respiratory tract infections.
出处
《中国现代应用药学》
CAS
CSCD
北大核心
2006年第3期244-245,共2页
Chinese Journal of Modern Applied Pharmacy
关键词
加替沙星
左氧氟沙星
药物经济学
下呼吸道感染
gatifloxaein
levofloxiaein
pharmaeoeeonomies
lower respiratory tract infections